WPD Pharmaceuticals Inc.

OTCPK:WPDP.D Stock Report

Market Cap: US$388.9k

WPD Pharmaceuticals Management

Management criteria checks 3/4

WPD Pharmaceuticals' CEO is Mariusz Olejniczak, appointed in Dec 2019, has a tenure of 5.08 years. directly owns 1.15% of the company’s shares, worth $4.47K. The average tenure of the management team and the board of directors is 4.3 years and 3.8 years respectively.

Key information

Mariusz Olejniczak

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.1yrs
CEO ownership1.2%
Management average tenure4.3yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mariusz Olejniczak's remuneration changed compared to WPD Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$7k

Jun 30 2024n/an/a

-CA$140k

Mar 31 2024n/an/a

-CA$200k

Dec 31 2023n/an/a

-CA$80k

Sep 30 2023n/an/a

CA$6m

Jun 30 2023n/an/a

CA$5m

Mar 31 2023n/an/a

CA$4m

Dec 31 2022CA$63kCA$63k

CA$4m

Sep 30 2022n/an/a

-CA$5m

Jun 30 2022n/an/a

-CA$5m

Mar 31 2022n/an/a

-CA$5m

Dec 31 2021CA$115kCA$115k

-CA$6m

Sep 30 2021n/an/a

-CA$5m

Jun 30 2021n/an/a

-CA$5m

Mar 31 2021n/an/a

-CA$6m

Dec 31 2020CA$113kCA$113k

-CA$8m

Sep 30 2020n/an/a

-CA$16m

Jun 30 2020n/an/a

-CA$16m

Mar 31 2020n/an/a

-CA$14m

Dec 31 2019CA$46kCA$42k

-CA$12m

Compensation vs Market: Insufficient data to establish whether Mariusz's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Mariusz's compensation has been consistent with company performance over the past year.

CEO

Mariusz Olejniczak

5.1yrs

Tenure

Mr. Mariusz Olejniczak serves as Chief Executive Officer at WPD Pharmaceuticals Inc since December 20, 2019. He is the Chief Executive Officer and Member of Management Board at Westcot Ventures Corp. He is...

Leadership Team

NamePositionTenureCompensationOwnership
Mariusz Olejniczak
Chief Executive Officer5.1yrsno data1.15%
$ 4.5k
Katarzyna Suchoszek
Chief Operating Officer3yrsno datano data
Beata Pajak
Chief Scientific Officerno datano datano data
Marek Sipowicz
Chief Medical Officer4.3yrsno datano data

4.3yrs

Average Tenure

Experienced Management: WPDP.D's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Romuald Harwas
Independent Director2.9yrsno datano data
Teresa Rzepczyk
Independent Director5.8yrsCA$7.50k0.11%
$ 442.6
Peter Novak
Independent Director5.1yrsno data0.39%
$ 1.5k
Waldemar Debinski
Member of Scientific Advisory Board4.8yrsno datano data
Nicholas Luksha
Independent Director1.8yrsno datano data
Constantine Carmichel
Independent Director1.7yrsno datano data

3.8yrs

Average Tenure

Experienced Board: WPDP.D's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 03:20
End of Day Share Price 2024/12/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

WPD Pharmaceuticals Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution